The AHA and ASA have replaced their 2016 stroke rehabilitation guideline with expanded, evidence-graded recommendations helping clinicians decide on care settings, comorbidity management, and ...
Subacute neurocognitive decline with multifocal enhancing lesions in immunosuppressed AQP4+ NMOSD warrants evaluation for EBV ...
The American Academy of Neurology (AAN) and American Headache Society (AHS) have issued an updated practice guideline on ...
Welcome to NeurologyLive® 's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive 's widespread coverage in ...
Sports neurologist Rory Siegel, DO, discusses the emerging evidence linking football participation with ALS, the potential role of repetitive head impacts, and key questions that remain about ...
FDA approval of apitegromab introduces a muscle-targeting approach to SMA treatment, with phase 3 data demonstrating ...
The FDA granted priority review to satralizumab for MOGAD, positioning it to become the first approved treatment for the rare ...
A new study suggests excessive daytime sleepiness in obstructive sleep apnea may be associated with cognitive impairment and ...
A 72% prevalence of excessive daytime sleepiness was identified using PDSS ≥15 among 1,616 adolescents aged 14–19 years in 20 ...
The phase 3 LUNA study showed that atogepant, an oral calcitonin gene-related peptide receptor antagonist, significantly reduced perimenstrual migraine days among patients with menstrual migraine ...
A lymphocyte-count polygenic score derived from Pan-UK Biobank GWAS data was inversely associated with grade 2 lymphopenia ...
The AAN and AHS have replaced their 2012 migraine prevention guideline with new, evidence-graded recommendations, giving neurologists clearer direction on when to start preventive therapy, how to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results